Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ·Healthcare·Biotechnology
$15.44
+0.32%
Mkt Cap $1.59B
Analyst Ratings
Buy
29
Hold
9
Sell
0
Price Target (67 analysts)
$26.25
Range $16.00 – $39.00
Implied Upside
+70.0%
Consensus $26.25 vs current $15.44
NASDAQ·Healthcare·Biotechnology
$15.44
+0.32%
Mkt Cap $1.59B
Buy
29
Hold
9
Sell
0
Price Target (67 analysts)
$26.25
Range $16.00 – $39.00
+70.0%
Consensus $26.25 vs current $15.44